Global Interventional X-ray Contrast and Imaging Agents Market Size, Share, Trends and Forecast 2021-2027

Description

The global Interventional X-ray Contrast and Imaging Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
Global Interventional X-ray Contrast and Imaging Agents Scope and Segment
Interventional X-ray Contrast and Imaging Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interventional X-ray Contrast and Imaging Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
The following manufacturers are covered in this report:
Bracco
General Electric
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
Unijules Life Sciences
Interventional X-ray Contrast and Imaging Agents Breakdown Data by Type
Iodinated Contrast Media
Barium-Based Contrast Media
Microbubble Contrast Media
Other
Interventional X-ray Contrast and Imaging Agents Breakdown Data by Application
Heart Disease
Neurological
Urology
General Surgery
Other
Regional and Country-level Analysis
The Interventional X-ray Contrast and Imaging Agents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Interventional X-ray Contrast and Imaging Agents market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.
Competitive Landscape and Interventional X-ray Contrast and Imaging Agents Market Share Analysis

TABLE OF CONTENT

1 Study Coverage
1.1 Interventional X-ray Contrast and Imaging Agents Product Introduction
1.2 Market by Type
1.2.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type
1.4.2 Iodinated Contrast Media
1.4.3 Barium-Based Contrast Media
1.2.4 Microbubble Contrast Media
1.2.5 Other
1.3 Market by Application
1.3.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application
1.3.2 Heart Disease
1.3.3 Neurological
1.3.4 Urology
1.3.5 General Surgery
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Interventional X-ray Contrast and Imaging Agents Sales Estimates and Forecasts 2016-2027
2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Estimates and Forecasts 2016-2027
2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Sales
2.4.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Sales (2016-2021)
2.4.2 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Sales (2022-2027)
2.5 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Revenue
2.5.1 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Revenue (2016-2021)
2.5.2 Global Top Interventional X-ray Contrast and Imaging Agents Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers
3.1.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Sales (2016-2021)
3.1.2 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Interventional X-ray Contrast and Imaging Agents Sales in 2020
3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers
3.2.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Interventional X-ray Contrast and Imaging Agents Revenue in 2020
3.3 Global Interventional X-ray Contrast and Imaging Agents Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Interventional X-ray Contrast and Imaging Agents Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Type
4.1.1 Global Interventional X-ray Contrast and Imaging Agents Historical Sales by Type (2016-2021)
4.1.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Sales by Type (2022-2027)
4.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2016-2027)
4.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type
4.2.1 Global Interventional X-ray Contrast and Imaging Agents Historical Revenue by Type (2016-2021)
4.2.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Revenue by Type (2022-2027)
4.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2016-2027)
4.3 Global Interventional X-ray Contrast and Imaging Agents Price by Type
4.3.1 Global Interventional X-ray Contrast and Imaging Agents Price by Type (2016-2021)
4.3.2 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Application
5.1.1 Global Interventional X-ray Contrast and Imaging Agents Historical Sales by Application (2016-2021)
5.1.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Sales by Application (2022-2027)
5.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2016-2027)
5.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Application
5.2.1 Global Interventional X-ray Contrast and Imaging Agents Historical Revenue by Application (2016-2021)
5.2.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Revenue by Application (2022-2027)
5.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2016-2027)
5.3 Global Interventional X-ray Contrast and Imaging Agents Price by Application
5.3.1 Global Interventional X-ray Contrast and Imaging Agents Price by Application (2016-2021)
5.3.2 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Application (2022-2027)

6 North America
6.1 North America Interventional X-ray Contrast and Imaging Agents Market Size by Type
6.1.1 North America Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2027)
6.1.2 North America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2016-2027)
6.2 North America Interventional X-ray Contrast and Imaging Agents Market Size by Application
6.2.1 North America Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2027)
6.2.2 North America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2016-2027)
6.3 North America Interventional X-ray Contrast and Imaging Agents Market Size by Country
6.3.1 North America Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2027)
6.3.2 North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Type
7.1.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2027)
7.1.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2027)
7.2 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Application
7.2.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2027)
7.2.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2027)
7.3 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Country
7.3.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2017-2027)
7.3.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Size by Type
8.1.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Type (2018-2027)
8.1.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Type (2018-2027)
8.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Size by Application
8.2.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Application (2018-2027)
8.2.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Application (2018-2027)
8.3 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Size by Region
8.3.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Region (2018-2027)
8.3.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Type
9.1.1 Latin America Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2027)
9.1.2 Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2027)
9.2 Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Application
9.2.1 Latin America Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2027)
9.2.2 Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2027)
9.3 Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Country
9.3.1 Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2027)
9.3.2 Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Size by Type
6.1.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2027)
6.1.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Type (2016-2027)
6.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Size by Application
6.2.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2027)
6.2.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Application (2016-2027)
6.3 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Size by Country
6.3.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2027)
6.3.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Bracco
11.1.1 Bracco Corporation Information
11.1.2 Bracco Overview
11.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bracco Interventional X-ray Contrast and Imaging Agents Product Description
11.1.5 Bracco Related Developments
11.2 General Electric
11.2.1 General Electric Corporation Information
11.2.2 General Electric Overview
11.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 General Electric Interventional X-ray Contrast and Imaging Agents Product Description
11.2.5 General Electric Related Developments
11.3 Guerbet
11.3.1 Guerbet Corporation Information
11.3.2 Guerbet Overview
11.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Guerbet Interventional X-ray Contrast and Imaging Agents Product Description
11.3.5 Guerbet Related Developments
11.4 Fujifilm Visualsonics
11.4.1 Fujifilm Visualsonics Corporation Information
11.4.2 Fujifilm Visualsonics Overview
11.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product Description
11.4.5 Fujifilm Visualsonics Related Developments
11.5 Imax
11.5.1 Imax Corporation Information
11.5.2 Imax Overview
11.5.3 Imax Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Imax Interventional X-ray Contrast and Imaging Agents Product Description
11.5.5 Imax Related Developments
11.6 J.B. Chemicals & Pharmaceuticals
11.6.1 J.B. Chemicals & Pharmaceuticals Corporation Information
11.6.2 J.B. Chemicals & Pharmaceuticals Overview
11.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Description
11.6.5 J.B. Chemicals & Pharmaceuticals Related Developments
11.7 Jodas Expoim
11.7.1 Jodas Expoim Corporation Information
11.7.2 Jodas Expoim Overview
11.7.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product Description
11.7.5 Jodas Expoim Related Developments
11.8 Lantheus Medical Imaging
11.8.1 Lantheus Medical Imaging Corporation Information
11.8.2 Lantheus Medical Imaging Overview
11.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product Description
11.8.5 Lantheus Medical Imaging Related Developments
11.9 Nano Therapeutics
11.9.1 Nano Therapeutics Corporation Information
11.9.2 Nano Therapeutics Overview
11.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product Description
11.9.5 Nano Therapeutics Related Developments
11.10 Novalek Pharmaceuticals
11.10.1 Novalek Pharmaceuticals Corporation Information
11.10.2 Novalek Pharmaceuticals Overview
11.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Description
11.10.5 Novalek Pharmaceuticals Related Developments
11.1 Bracco
11.1.1 Bracco Corporation Information
11.1.2 Bracco Overview
11.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bracco Interventional X-ray Contrast and Imaging Agents Product Description
11.1.5 Bracco Related Developments
11.12 Unijules Life Sciences
11.12.1 Unijules Life Sciences Corporation Information
11.12.2 Unijules Life Sciences Overview
11.12.3 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Unijules Life Sciences Product Description
11.12.5 Unijules Life Sciences Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Interventional X-ray Contrast and Imaging Agents Value Chain Analysis
12.2 Interventional X-ray Contrast and Imaging Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Interventional X-ray Contrast and Imaging Agents Production Mode & Process
12.4 Interventional X-ray Contrast and Imaging Agents Sales and Marketing
12.4.1 Interventional X-ray Contrast and Imaging Agents Sales Channels
12.4.2 Interventional X-ray Contrast and Imaging Agents Distributors
12.5 Interventional X-ray Contrast and Imaging Agents Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Interventional X-ray Contrast and Imaging Agents Industry Trends
13.2 Interventional X-ray Contrast and Imaging Agents Market Drivers
13.3 Interventional X-ray Contrast and Imaging Agents Market Challenges
13.4 Interventional X-ray Contrast and Imaging Agents Market Restraints

14 Key Findings in The Global Interventional X-ray Contrast and Imaging Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample